Stereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

Recruiting

Phase 2

Stereotactic Boost and Short-course Radiation Therapy for Oropharynx CancerStereotactic Boost and Short-course Radiation Therapy for Oropharynx Cancer

Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Code:

NCT04178174

Conditions

Head and Neck Cancer

Oropharynx Cancer

Human Papilloma Virus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SABR boost and de-escalated chemoradiation

Standard chemoradiation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Centre hospitalier de l'Université de Montréal (CHUM) on 2025-03-25.